name: Eylea Treat and Extend
version: '1.0'
created_date: '2024-01-15'
author: Clinical Team
description: Standard treat-and-extend protocol for Eylea (aflibercept) based on clinical
  trial data
protocol_type: treat_and_extend
min_interval_days: 56
max_interval_days: 112
extension_days: 14
shortening_days: 14
disease_transitions:
  NAIVE:
    NAIVE: 0.0
    STABLE: 0.3
    ACTIVE: 0.6
    HIGHLY_ACTIVE: 0.1
  STABLE:
    NAIVE: 0.0
    STABLE: 0.85
    ACTIVE: 0.15
    HIGHLY_ACTIVE: 0.0
  ACTIVE:
    NAIVE: 0.0
    STABLE: 0.2
    ACTIVE: 0.7
    HIGHLY_ACTIVE: 0.1
  HIGHLY_ACTIVE:
    NAIVE: 0.0
    STABLE: 0.05
    ACTIVE: 0.15
    HIGHLY_ACTIVE: 0.8
treatment_effect_on_transitions:
  NAIVE:
    multipliers: {}
  STABLE:
    multipliers:
      STABLE: 1.1
      ACTIVE: 0.9
  ACTIVE:
    multipliers:
      STABLE: 2.0
      ACTIVE: 0.8
      HIGHLY_ACTIVE: 0.5
  HIGHLY_ACTIVE:
    multipliers:
      STABLE: 2.0
      ACTIVE: 1.5
      HIGHLY_ACTIVE: 0.75
vision_change_model:
  naive_treated:
    mean: 0
    std: 1
  naive_untreated:
    mean: -2
    std: 2
  stable_treated:
    mean: 1
    std: 1
  stable_untreated:
    mean: 0
    std: 1
  active_treated:
    mean: -1
    std: 2
  active_untreated:
    mean: -3
    std: 2
  highly_active_treated:
    mean: -2
    std: 2
  highly_active_untreated:
    mean: -5
    std: 3
baseline_vision_distribution:
  type: normal
  mean: 70
  std: 10
  min: 20
  max: 90
discontinuation_rules:
  poor_vision_threshold: 35
  poor_vision_probability: 0.1
  high_injection_count: 20
  high_injection_probability: 0.02
  long_treatment_months: 36
  long_treatment_probability: 0.01
  discontinuation_types:
  - planned
  - adverse
  - ineffective
mortality:
  enabled: true
  base_annual_rate: 0.078
  monthly_rate: 0.0065
  age_adjustment:
    enabled: true
    reference_age: 89.5
    min_age: 70
    max_age: 106
    comment: Mortality risk doubles approximately every 8 years
  treatment_gap_multipliers:
    regular: 1.0
    short_gap: 1.22
    long_gap: 1.34
    discontinued: 1.37
    comment: Multipliers based on observed mortality by treatment pattern
  data_source: Real-world Eylea patient data (n=1,775, 2007-2025)
  notes:
  - Based on 7.8 deaths per 100 patient-years
  - 'Average age at death: 89.5 years'
  - Treatment gaps significantly increase mortality risk
clinical_improvements:
  enabled: true
  use_loading_phase: true
  use_time_based_discontinuation: true
  use_response_based_vision: true
  use_baseline_distribution: true
  use_response_heterogeneity: true
  response_types:
    good:
      probability: 0.3
      multiplier: 2.0
    average:
      probability: 0.5
      multiplier: 1.0
    poor:
      probability: 0.2
      multiplier: 0.5
  discontinuation_probabilities:
    1: 0.1
    2: 0.18
    3: 0.12
    4: 0.08
    5: 0.075
